Globally, 2.9k objects were placed in orbit in 2024; 3.6k added to debris
A dense cluster of defunct satellites and fragmented metal orbits Earth. (AI-generated image)
BENGALURU: Globally, 2024 continued to see a significant number of space launches, with 261 attempts and 254 successes, resulting in 2,578 operational satellites and a total of 2,963 objects placed in orbit, although the total objects placed in orbit is slightly lower than the 3,135 objects from 212 launches in 2023.
Revealing these details, the
Indian Space Situational Assessment Report
(ISSAR) for 2024, also said that renewed interest in lunar missions was evident, with five lunar missions launched during the year. However, 2024 also witnessed three significant on-orbit fragmentation events, including the breakup of a Chinese Long March rocket stage (CZ-6A), which alone added approximately 650 catalogued objects to space debris.
These events contributed to a net addition of 702 fragmented objects by year's end. In total, 3,665 objects from launches and fragmentation events were added to the space object population. Simultaneously, a record 2,095 catalogued objects re-entered Earth's atmosphere, including 335 Starlink satellites deliberately deorbited.
'This increase in re-entries was influenced by intense solar activity as the peak of Solar Cycle 25 approached, featuring 18 strong (G3), 20 severe (G4), and 2 extreme (G5) geomagnetic storms that accelerated orbital decay,' the report noted.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
2025 Top Trending local enterprise accounting software [Click Here]
Esseps
Learn More
Undo
Indian endeavors
By Dec 31, 2024, India had a total of 136 spacecraft, encompassing government, private, and academic initiatives. The government operated 22 satellites in Low Earth Orbit (LEO) and 31 in Geosynchronous Earth Orbit (GEO). Additionally, two deep space missions—Chandrayaan-2 Orbiter and Aditya-L1 at the Sun-Earth Lagrange point—remained active.
The propulsion module of Chandrayaan-3 continued operations in a high Earth orbit after its relocation from lunar orbit in Nov 2023.
India conducted five successful launches from Sriharikota: the PSLV-C58 carrying XPoSat, PSLV-C59 carrying Proba-3, PSLV-C60 that launched the SpaDex satellites, GSLV-F14 carrying the Insat-3ds, and the SSLV-D3/EOS-08. Additionally, GSAT-20 and TSAT-1A were launched aboard SpaceX's Falcon-9 from Cape Canaveral. Collectively, these missions added eight Indian satellites, one foreign satellite, and six rocket bodies to orbit.
Re-entry & decommissioning
Thirty-four Indian rocket bodies re-entered Earth's atmosphere by Dec 2024—five of them in 2024. 'All LVM3 stages have decayed except the one from LVM3 M2 (OneWeb India-1). Only GSLV-F12 and F14 stages remain in orbit,' the report reads.
A total of 31 Indian satellites have re-entered so far, with 9 in 2024. Cartosat-2 was the first Isro LEO satellite de-orbited at end-of-life to cut its orbital life from 30 to under four years. Scatsat-1 was deorbited in 12 manoeuvres and passivated on Sept 26, 2024, eight years post-launch. The INS-2B and EOS-7 were also decommissioned before re-entry.
Collision avoidance & risk mitigation
Isro analysed over 53,000 close approach alerts in 2024. Ten Collision Avoidance Manoeuvres (CAMs) were executed—six in LEO and four in GEO. An additional CAM was performed for Chandrayaan-2, with its orbit manoeuvre advanced to avoid Nasa's LRO.
CAMs were fewer than in 2023, thanks to refined analysis and the integration of avoidance within regular orbit manoeuvres. 'In 2024, Isro carried out 681 orbit manoeuvres in LEO, 504 in GEO, 21 in deep space (Chandrayaan-2 and Aditya-L1). Eighty-nine LEO and two GEO manoeuvre plans were revised to avoid post-manoeuvre conjunctions,' the report noted.
Also, Launch Vehicle Clearance (COLA) assessments were conducted for all 2024 launches. Only PSLV-C60 was delayed (by 2 mins 15 secs) due to collision risk. All other missions proceeded on schedule.
Isro also deorbited its POEM-3 and POEM-4 platforms that carried 9 and 24 payloads, respectively. 'Both upper stages were de-orbited to \~350 km and passivated, limiting their life to around 3 months,' the report noted.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
35 minutes ago
- Time of India
Kidney transplant turns dangerous after parasite found in donor organ
A routine kidney transplant meant to save a man's life nearly cost him everything—because of a parasite no one saw coming. Two months after undergoing what should have been a life-improving surgery, a 61-year-old man was rushed back to the hospital in distress. He wasn't just feeling unwell—he was vomiting, severely fatigued, constantly thirsty, and urinating excessively. As his symptoms escalated, his oxygen levels dropped and fluid began to accumulate in his lungs. Despite being placed on a feeding tube, his condition worsened. Doctors transferred him to intensive care and began a frantic search for answers. According to a detailed case report in the New England Journal of Medicine, physicians at Massachusetts General Hospital suspected an infection but were faced with a daunting challenge: the man was on powerful immunosuppressive drugs following his transplant, which meant nearly any infectious agent could be the cause. What did they find? Dr. Camille Kotton, Clinical Director of the Transplant and Immunocompromised Host Infectious Diseases division at Mass General, was part of the team trying to find the cause. As reported by Ars Technica, she began by ruling out likely viral infections, since the patient was already on preventative medications. But when she noticed two unusual signs—a significant rise in eosinophils (a type of white blood cell linked to parasitic infections) and a reddish-purple rash on the patient's abdomen—her attention turned toward a lesser-considered threat: a parasitic roundworm called Strongyloides. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Giao dịch CFD với công nghệ và tốc độ tốt hơn IC Markets Tìm hiểu thêm Undo This worm typically infects the gastrointestinal tract and can become deadly when undiagnosed in immunocompromised individuals. To follow her hunch, Dr. Kotton contacted the organ-procurement organization and learned that the donor had lived in the Caribbean, a region where Strongyloides is endemic. The donor's blood hadn't been tested for the parasite prior to organ recovery, but stored samples later revealed antibodies against it. Meanwhile, the transplant recipient's pre-transplant blood was negative—confirming that the infection had come from the donor. What was the path to recovery? T ests soon uncovered worm larvae in the patient's lungs and stool. The treatment required ivermectin, a deworming medication approved by the FDA only for oral use in humans. With special approval, doctors administered the drug subcutaneously. Slowly, the patient began to recover. Then came another shock: the recipient of the donor's other kidney had also fallen critically ill. When doctors exchanged notes, they found the same parasite at work. Fortunately, both patients survived. In response to the case, the United Network for Organ Sharing has since revised its transplant screening guidelines, now recommending universal Strongyloides testing for donors from high-risk regions. The case serves as a stark reminder that even life-saving procedures can carry hidden dangers—and that vigilance doesn't end with the operating room. One step to a healthier you—join Times Health+ Yoga and feel the change
Time of India
an hour ago
- Time of India
KU preferred institution among foreign students
T'puram: The University of Kerala is fast establishing itself as a leading international education destination, experiencing significant growth in foreign student enrolments over four years. For the 2025-26 academic year, the institution received 2,620 applications from 81 nations, marking a substantial increase from 1,100 students in 2021-22. According to Prof Sabu Joseph, director of the Centre for Global Academics (CGA), the university maintains its position as Kerala's foremost institution for international student intake. "The numbers demonstrate consistent growth 1,100 students from 35 countries in 2021-22, increasing to 1,400 in 2022-23, 1,600 in 2023-24 and 2,600 in 2024-25 from 64 countries. The 2025-26 academic year saw 2,620 applications from 81 countries, all submitted to the Indian Council for Cultural Relations (ICCR) portal for selection," he said. The current application distribution includes 1,265 for undergraduate programmes, 1,020 for postgraduate courses, and 335 for PhD studies. African nations constitute the largest applicant group, with sizeable applications from Iran, Iraq, Oman, Saudi Arabia, Sri Lanka, Nepal, Bangladesh, Philippines, Bhutan, Turkmenistan, Tajikistan, Indonesia, Malaysia, Jordan, Thailand, Vietnam, South Africa, Russia, France, and the USA. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Over 40 and Struggling With Belly Fat? Try 1 Teaspoon Daily (See What Happens A Week Later) Health Benefits Undo Popular course selections focus on commerce and management studies, with strong interest in political science, psychology, economics, education, linguistics and English literature. Scientific disciplines, including computer science, biotechnology, chemistry, environmental sciences, mathematics, physics and statistics also attract applicants. The university currently hosts 205 international students from 52 countries, including Colombia, Peru, UK, and the USA, through ICCR scholarships and self-financing options. Support services include orientation programmes, cultural events, and annual graduation ceremonies, creating an inclusive academic environment. "The university's NAAC A++ accreditation, strong NIRF rankings, efficient admission procedures, and advanced research facilities have established its position as a preferred international education hub. This sustained growth reflects its increasing global influence and dedication to academic excellence and multicultural education," said Sabu Joseph, adding that the KU continues to strengthen its position as an educational leader.
Time of India
3 hours ago
- Time of India
Axiom-4 astronauts to study insulin behaviour in microgravity, revolutionise diabetes treatment
New Delhi: Indian astronaut Shubhanshu Shukla's Axiom-4 mission to the International Space Station (ISS) is set to offer a ray of hope for diabetics to travel to space, as a UAE-based healthcare provider is conducting an experiment on how glucose behaves in microgravity part of the "Suite Ride" experiment planned by Burjeel Holdings and Axiom Space, some astronauts of the Axiom-4 mission will be wearing continuous glucose monitors during their 14-day stay on board the orbital lab. The studies of the behaviour of glucose and insulin in microgravity conditions will help scientists develop wearable technologies for astronauts and patients who are bedridden or have limited mobility due to illnesses such as paralysis. "We are trying just to see if there is any change or fluctuation to the blood-sugar levels while they are in space," Mohammad Fityan, chief medical officer at Burjeel Holdings, Abu Dhabi, told PTI. The astronauts will also carry insulin pens in refrigerated and ambient temperatures to examine how the molecules respond to microgravity conditions. "We are hoping that if we learn something about the metabolism or the effect, we will bring some information and we can do something for our patients on Earth," Fityan said. Currently, the National Aeronautics and Space Administration (NASA) does not allow insulin-dependent diabetics to travel to space. There are no official exclusions for non-insulin-dependent diabetics, but so far, no astronaut with diabetes has travelled to space. "It has the potential to transform the future of space travel for astronauts with insulin-dependent diabetes mellitus (IDDM), a condition historically considered disqualifying for space missions," Fityan said. He said the study will pave the way for several innovative technologies and treatment approaches for developing advanced glucose-monitoring tools optimised for extreme or low-activity environments, improving wearable tech for both astronauts and patients with limited mobility on Earth. It will also help identify new pharmacologic targets by observing how metabolic and hormonal responses change in microgravity, leading to drugs that enhance insulin sensitivity or mimic the benefits of exercise in sedentary individuals. The AI-powered predictive models based on real-time physiologic data in space can be adapted to personalise diabetes care on Earth by forecasting insulin needs or metabolic shifts with higher accuracy. The research will also help develop remote monitoring platforms for continuous metabolic-data capture that could revolutionise diabetes care in underserved or remote areas on Earth as well as in tele-health settings.
